CELLnTEC is a pioneering developer of chemically defined, xeno-free, and serum-free cell culture systems. We develop high-performance, precision media for human primary cells, stem cells, iPSCs, and advanced in vitro 3D models.
Our products eliminate animal components, supporting ethical, human-relevant, and regulatory-compliant science. Our solutions ensure reproducibility, consistency, and clinical readiness – trusted worldwide by biotech, pharma, and academic research labs.
Material selection is a critical strategic decision at project initiation. Inapt materials can lead to significant time and cost implications. CELLnTEC materials are designed for a seamless transition from the research stage to clinical development and beyond.
Our media support the growth of epithelial, mesenchymal, and induced pluripotent stem cells (iPSCs) across 2D and 3D culture systems.
As you scale your research from lab to clinical or commercial manufacturing, we take care of your volume and format requirements. We accompany you with our process engineering and biological expertise from small to large liquid volumes, from bottles to bags.
Replacing animal testing and embracing the 3R principles have been part of CELLnTEC’s founding vision. Today, we advance this mission by enabling New Approach Methods (NAMs) that drive ethical, human-relevant research.
To deliver meticulously defined, xeno-free, and serum-free cell culture media to build sophisticated, human-relevant in vitro cell systems. To remove unwanted biological background from cell culture and provide you with a pristine biochemical environment. To help you benefit from enhanced standardization, reduced variability, and cleaner, background-free data. Enable reliable, ethical, and high-performance cell-based research – bridging the gap between laboratory discovery and translational medicine.
We envision a future where human-relevant cell culture systems and regenerative medicine replace animal testing, where 3D bioprinting and organotypic models become standard tools in biotech and life sciences, and where the research-to-clinic gap is significantly narrowed. We are dedicated to the 3Rs principle (Replace, Reduce, Refine) to advance the shift from animal-based testing to precise, human-based in vitro systems. We believe that our precision cell culture facilitates New Approach Methods (NAMs) and is at the heart of future innovation and personalized therapies.
To deliver meticulously defined, xeno-free, and serum-free cell culture media to build sophisticated, human-relevant in vitro cell systems. To remove unwanted biological background from cell culture and provide you with a pristine biochemical environment. To help you benefit from enhanced standardization, reduced variability, and cleaner, background-free data. Enable reliable, ethical, and high-performance cell-based research – bridging the gap between laboratory discovery and translational medicine.
We envision a future where human-relevant cell culture systems and regenerative medicine replace animal testing, where 3D bioprinting and organotypic models become standard tools in biotech and life sciences, and where the research-to-clinic gap is significantly narrowed. We are dedicated to the 3Rs principle (Replace, Reduce, Refine) to advance the shift from animal-based testing to precise, human-based in vitro systems. We believe that our precision cell culture facilitates New Approach Methods (NAMs) and is at the heart of future innovation and personalized therapies.
From basic research to translational development, we offer serum-free, animal-component-free, and higher-certified (HC) versions to support regulatory-compliant processes and reduce late-stage failure risk.
Whether you’re working with iPSCs, MSCs, epithelial, or endothelial cell types, our media are optimized for both standard and advanced applications, such as 3D models and bioprinting.
We are proud of our reputation for quality. Our precision biochemistries deliver flawless quality and unmatched consistency across lots and experimental runs.
Our media formulations are built on a proprietary universal base platform, ensuring reproducibility and seamless workflow transitions from isolation to proliferation, differentiation, homeostasis, ageing, and cryopreservation.
Promoting the replacement and reduction of animal components aligns with our vision of responsible life science innovation. Our sophisticated human cell-based test systems help labs move towards more ethical, relevant research models.
Chair, Founder
Vice-Chair
Member of the Board
Member of the Board
Member of the Board
Member of the Board
Chair, Founder
Vice-Chair
Member of the Board
Member of the Board
Member of the Board
We collaborate with renowned research institutions, regulatory-compliant manufacturing partners, and industry-leading distributors worldwide. Our strategic partnerships enable us to expand access to advanced cell culture solutions, co-develop workflow-optimized products, and integrate seamlessly into global translational pipelines. Together, we support innovation in regenerative medicine, in vitro modelling, cosmetic testing, 3D bioprinting, and clinical applications.
Stay tuned for our latest announcements: new product launches, proprietary media formulation releases, collaborations in regenerative medicine and 3D bioprinting, subscription to our newsletter, and upcoming events. Visit our News & blogs page to keep up with CELLnTEC’s innovations and breakthroughs.
